Related references
Note: Only part of the references are listed.In Vitro Combination of Anidulafungin and Voriconazole against Intrinsically Azole-Susceptible and -Resistant Aspergillus spp.
Virginie Planche et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2012)
Isolation of multiple-triazole-resistant Aspergillus fumigatus strains carrying the TR/L98H mutations in the cyp51A gene in India
Anuradha Chowdhary et al.
JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY (2012)
Azole Resistance in Aspergillus fumigatus Isolates from the ARTEMIS Global Surveillance Study Is Primarily Due to the TR/L98H Mutation in the cyp51A Gene
Shawn R. Lockhart et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2011)
Assessment of efficacy of antifungals in experimental models of invasive aspergillosis in an era of emerging resistance: the value of real-time quantitative PCR
Seyedmojtaba Seyedmousavi et al.
CURRENT OPINION IN PHARMACOLOGY (2011)
Pharmacokinetics and Pharmacodynamics of Posaconazole for Invasive Pulmonary Aspergillosis: Clinical Implications for Antifungal Therapy
Susan J. Howard et al.
JOURNAL OF INFECTIOUS DISEASES (2011)
Clinical Implications of Azole Resistance in Aspergillus fumigatus, the Netherlands, 2007-2009
Jan W. M. van der Linden et al.
EMERGING INFECTIOUS DISEASES (2011)
Efficacy of Posaconazole against Three Clinical Aspergillus fumigatus Isolates with Mutations in the cyp51A Gene
Eleftheria Mavridou et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2010)
Impact of cyp51A Mutations on the Pharmacokinetic and Pharmacodynamic Properties of Voriconazole in a Murine Model of Disseminated Aspergillosis
Eleftheria Mavridou et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2010)
Combination Therapy in Treatment of Experimental Pulmonary Aspergillosis: In Vitro and In Vivo Correlations of the Concentration- and Dose-Dependent Interactions between Anidulafungin and Voriconazole by Bliss Independence Drug Interaction Analysis
Vidmantas Petraitis et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2009)
Combination Therapy of Advanced Invasive Pulmonary Aspergillosis in Transiently Neutropenic Rats Using Human Pharmacokinetic Equivalent Doses of Voriconazole and Anidulafungin
Wendy W. J. van de Sande et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2009)
Azole-resistance in Aspergillus: Proposed nomenclature and breakpoints
Paul E. Verweij et al.
DRUG RESISTANCE UPDATES (2009)
Susceptibility testing of anidulafungin and voriconazole alone and in combination against conidia and hyphae of Aspergillus spp. under hypoxic conditions
Susanne Perkhofer et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2008)
Treatment of aspergillosis: Clinical practice guidelines of the infectious diseases society of America
Thomas J. Walsh et al.
CLINICAL INFECTIOUS DISEASES (2008)
EUCAST Technical Note on the method for the determination of broth dilution minimum inhibitory concentrations of antifungal agents for conidia-forming moulds - Subcommittee on antifungal susceptibility testing (AFST) of the ESCMID European committee for antimicrobial susceptibility testing (EUCAST)
J. -L. Rodriquez Tudela et al.
CLINICAL MICROBIOLOGY AND INFECTION (2008)
Emergence of Azole Resistance in Aspergillus fumigatus and Spread of a Single Resistance Mechanism
Eveline Snelders et al.
PLOS MEDICINE (2008)
Multiple-triazole-resistant aspergillosis
Paul E. Verweij et al.
NEW ENGLAND JOURNAL OF MEDICINE (2007)
Concentration-dependent effects of caspofungin on the metabolic activity of Aspergillus species
Charalampos Antachopoulos et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2007)
Multicenter, noncomparative study of caspofungin in combination with other antifungals as salvage therapy in adults with invasive aspergillosis
Johan Maertens et al.
CANCER (2006)
Multi-azole resistance in Aspergillus fumigatus
Susan J. Howard et al.
INTERNATIONAL JOURNAL OF ANTIMICROBIAL AGENTS (2006)
Micafungin in combination with voriconazole in Aspergillus species:: a pharmacodynamic approach for detection of combined antifungal activity in vitro
RE Lewis et al.
JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY (2005)
In vitro synergy testing of anidulafungin with itraconazole, voriconazole, and amphotericin B against Aspergillus spp. and Fusatium spp.
A Philip et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2005)
Combined activity in vitro of caspofungin, amphotericin B, and azole agents against itraconazole-resistant clinical isolates of Aspergillus fumigatus
M Cuenca-Estrella et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2005)
Combination treatment of invasive fungal infections
PK Mukherjee et al.
CLINICAL MICROBIOLOGY REVIEWS (2005)
Combination antifungal therapy
MD Johnson et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2004)
Combination antifungal therapy for invasive aspergillosis
KA Marr et al.
CLINICAL INFECTIOUS DISEASES (2004)
Invasive aspergillosis in critically ill patients without malignancy
W Meersseman et al.
AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE (2004)
Combination chemotherapy for invasive fungal infections: what laboratory and clinical studies tell us so far
DP Kontoyiannis et al.
DRUG RESISTANCE UPDATES (2003)
Combination therapy in treatment of experimental pulmonary aspergillosis: Synergistic interaction between an antifungal triazole and an echinocandin
V Petraitis et al.
JOURNAL OF INFECTIOUS DISEASES (2003)
In vitro synergy of caspofungin and itraconazole against Aspergillus spp.:: MIC versus minimal effective concentration end points
I Shalit et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2003)
Voriconazole, a novel wide-spectrum triazole: oral pharmacokinetics and safety
L Purkins et al.
BRITISH JOURNAL OF CLINICAL PHARMACOLOGY (2003)
Aspergillosis - Pathogenesis, clinical manifestations, and therapy
KA Marr et al.
INFECTIOUS DISEASE CLINICS OF NORTH AMERICA (2002)
In vitro interaction of caspofungin acetate with voriconazole against clinical isolates of Aspergillus spp.
S Perea et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2002)
Voriconazole versus amphotericin B for primary therapy of invasive aspergillosis
R Herbrecht et al.
NEW ENGLAND JOURNAL OF MEDICINE (2002)
Efficacy of caspofungin alone and in combination with voriconazole in a guinea pig model of invasive aspergillosis
WR Kirkpatrick et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2002)
In vitro synergy of caspofungin and amphotericin B against Aspergillus and Fusarium spp.
S Arikan et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2002)
Colorimetric assay for antifungal susceptibility testing of Aspergillus species
J Meletiadis et al.
JOURNAL OF CLINICAL MICROBIOLOGY (2001)
Share Paper
